BioForce Nanosciences Holdings, Inc. (BFNH)
OTCMKTS · Delayed Price · Currency is USD
0.499
0.00 (0.00%)
At close: Mar 4, 2026

BFNH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
0.50.490.470.490.5158.41
Upgrade
Operating Expenses
0.50.490.470.490.5158.41
Upgrade
Operating Income
-0.5-0.49-0.47-0.49-0.5-158.41
Upgrade
EBT Excluding Unusual Items
-0.5-0.49-0.47-0.49-0.5-158.41
Upgrade
Other Unusual Items
-0.8-----
Upgrade
Pretax Income
-1.3-0.49-0.47-0.49-0.5-158.41
Upgrade
Net Income
-1.3-0.49-0.47-0.49-0.5-158.41
Upgrade
Net Income to Common
-1.3-0.49-0.47-0.49-0.5-158.41
Upgrade
Shares Outstanding (Basic)
322929292916
Upgrade
Shares Outstanding (Diluted)
322929292916
Upgrade
Shares Change (YoY)
9.81%---79.53%6.81%
Upgrade
EPS (Basic)
-0.04-0.02-0.02-0.02-0.02-9.72
Upgrade
EPS (Diluted)
-0.04-0.02-0.02-0.02-0.02-9.72
Upgrade
Free Cash Flow
-0.07-0.06-0.05-0.07-0.08-0.08
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00-0.01
Upgrade
EBIT
-0.5-0.49-0.47-0.49-0.5-158.41
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.